Did any holders here ever find out if they conducted a phase I clinical trial for Cognicann? Would be interesting to see what those results are as they don't seem to be publicly available.
Also just wanted to post a little snippet from their first announcement on this phase II trial back on the 27th of August 2018 'The Western Australian based trial is expected to commence in early 2019'.
If they were expecting to start the trial in early 2019, then what was the cause of the delay?
Consequently, this dot point from today's announcement seems fishy since they are three quarters behind when they expected to commence the trial: 'The University has received a high level of interest to participate in its Phase IIb trial of the benefits of CogniCann® in dementia and Alzheimer’s disease patients'. If that were the case that they had a high level of interest from potential participants, again I pose the question, what was the cause of the delay?
MXC Price at posting:
3.2¢ Sentiment: None Disclosure: Not Held
